Yuliya K. Ziemann, APRN

Yuliya Ziemann practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Yuliya Ziemann's NPI, 1275199598, was assigned on May 13, 2019. Yuliya Ziemann holds Florida license APRN11034164.

Yuliya Ziemann's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Yuliya Ziemann's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Yuliya Ziemann is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Community Physicians. Dmand AI also links Yuliya Ziemann to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Yuliya Ziemann practices, 3 sites in all. Vendor and product names are available with a free account.

Gerontology is Yuliya Ziemann's primary specialty in the NPI Registry, under taxonomy code 363LG0600X. Dmand AI has Yuliya Ziemann's licenses on file in 3 states: Florida, New York and Ohio.

CMS data shows 147 Medicare services from Yuliya Ziemann across 4 procedure codes in 2024, for 111 Medicare patients. Medicare paid $8,993 for them. Every service was in an office.

CMS counts 111 Medicare patients who saw Yuliya Ziemann in 2024. The largest group is 65 to 74, with 54 patients. 74% of them have high cholesterol, and 70% have high blood pressure. 11% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Yuliya Ziemann's median patient age at 49, with 68% women.

In 2024, Yuliya Ziemann wrote 535 Medicare Part D claims for 133 patients. 56% of them were for generic drugs. CMS names the drug for 361 of them, across 14 drugs with 11 or more claims each, at $2,301,142 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Yuliya Ziemann for performance year 2024, reported as part of a group. Yuliya Ziemann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Yuliya Ziemann as offering telehealth.

CMS Open Payments shows 28 general payments to Yuliya Ziemann from 18 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $128.